ADC Therapeutics SA
ADCT
$1.29
-$0.01-0.77%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 49.75% | -414.40% | 84.36% | 27.68% | -46.74% |
| Total Depreciation and Amortization | -200.00% | 0.88% | -7.38% | 126.58% | -200.00% |
| Total Amortization of Deferred Charges | 317.78% | -8.54% | -66.44% | 12.77% | 240.31% |
| Total Other Non-Cash Items | -206.03% | 158.72% | -233.75% | -40.73% | 52.89% |
| Change in Net Operating Assets | 346.43% | 56.78% | -3,053.83% | -97.45% | 152.00% |
| Cash from Operations | 60.26% | 4.54% | -5.04% | -23.01% | 57.24% |
| Capital Expenditure | 100.00% | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -104.86% | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -42.44% | -99.65% | -- | -- | 34,598.52% |
| Repurchase of Common Stock | 71.74% | 39.24% | -538.38% | 20.80% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Financing | 83.02% | -101.02% | 28,932.83% | -100.21% | 34,506.27% |
| Foreign Exchange rate Adjustments | 200.00% | 80.00% | -516.67% | -96.32% | 1.24% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 60.76% | -214.02% | 189.20% | -142.69% | 224.38% |